Search - tctmd.com

Displaying 41 - 49 of 49

Sort: Relevancy | Date

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Dean J. Kereiakes

September 14, 2014

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

Presentation TCT 2012

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Presenter: Dean J. Kereiakes, Louis A. Cannon, John A. Ormiston, Hong Wang, Paul L. Underwood, Keith D. Dawkins

January 03, 2012

Presentation TCT 2012

Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results.

Presenter: Louis A. Cannon, Dean J. Kereiakes, Wayne Batchelor, Albert Deibele, James Hopkins, Robert E. Foster, Paul Underwood, Keith D. Dawkins

January 03, 2012

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

Advertisement

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents.

Long-Term Follow-up of the Platinum Chromium TAXUS Element (ION) Stent: PERSEUS Two-Year Results.

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content